Join us:
January 10–12, 2022 in-personJanuary 17–19, 2022 virtually

PRESENTATION INFORMATION FOR CHINA SHOWCASE

Presenting allows companies to raise their profile with potential investors and strategic partners, and includes one-to-one meetings and informal networking.

We are no longer accepting requests to present.

Opportunities To Request a Presentation Slot

Qualified Company Categories

Presentation slots are open to all therapeutic categories including:

  • Small/large molecule R&D therapeutics
  • Platform
  • Digital Therapeutic and Medtech Companies
  • Tool/Device companies
  • Drug Delivery
  • Molecular Diagnostic and Personalized Medicine
  • Research Focused Service Providers

Public Company Presentation

Mid- and small-cap public life science companies are invited to request a presentation slot. Presenting at China Showcase allows companies to build their profile with investors and strategic partners. 


Fee structure

  • Presentation fee per company:  $2,300
  • Registration fee per presenter: $1,495         
  • Total fee: $3,795

Includes: One registration for the presenter.
A pre-recorded 30-minute on-demand presentation.

Private Company Presentation

Venture and angel-backed private life science companies are invited to request a presentation slot. Presenting at China Showcase Showcase allows companies to build their profile with investors and strategic partners.

Fee structure

  • Presentation fee per company:  $1,200
  • Registration fee per presenter: $1,495          
  • Total fee: $2,695

Includes: One registration for the presenter.
A pre-recorded 15-minute on-demand presentation.

Presentation and Registration fees will go up $100 each after October 16!

DID YOU KNOW?

That in just the past five years, 250 companies that presented at Biotech Showcase™ have generated deals worth over $61bn*? 

Discover what Informa Pharma Intelligence analysts learned when they dissected the dealmaking data of hundreds of companies that presented at Biotech Showcase.

Enhanced Support For All Presenting Companies

Marketing:

We continue to enhance our marketing efforts for presenting companies.  Activities include:

  • Two unique Twitter posts per company, indicating selection to present and presentation date and time.
  • Promotional emails and posts on all media channels leading up to the conference.
  • Distribution of presenting company list to pharma and investors to support organizing meetings.

Media:

  • Embargoed News: Companies with important announcements are encouraged to embargo their news or press releases (provide copy ahead of distribution date), before and during the event. Presenting companies can confidentially share their news by sending an email including a press release or send a summary of announcement to our media team. Our team will share this news with media outlets and press attending the conference. All embargo dates will be strictly adhered to as indicated by the presenting company.
  • Press Releases: Press releases provided by presenting companies will be distributed to our network of investors, pharma and biotech execs via our social media channels.
  • Press Release Templates: A template to announce that the company has been selected to present and the date/time of the presentation will be provided to presenters.

MORE INFORMATION & QUESTIONS?

Presenter Guidelines

About a presentation slot?

Lawrence Joseph
Demy-Colton
+1 646-895-0981
ljoseph@demy-colton.com

About submitting a request to present?

Lila Taylor
Demy-Colton
+1 510 379 4090
ltaylor@demy-colton.com

For all other questions please contact conferences@ebdgroup.com.